AI assistant
DEXCOM INC — Director's Dealing 2022
May 23, 2022
30198_dirs_2022-05-23_3fdf0965-6b0f-4596-83c1-a664adbd2668.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2022-05-20
Reporting Person: TOPOL ERIC (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-19 | Common Stock | J | 919 | $0.0 | Disposed | 0 | Direct |
| 2022-05-20 | Common Stock | A | 988 | $0.001 | Acquired | 988 | Direct |
| 2022-05-19 | Common Stock | J | 919 | $0.0 | Acquired | 92766 | Indirect |
Footnotes
F1: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units.
F2: The RSU Award was granted on May 20, 2022 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F3: Represents 988 restricted stock units which were granted on May 20, 2022 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2023 Annual Meeting.
F4: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares.